Delivery Order SPE2DB22D3401-SPE2DB23FT5BM
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 40,000 units of the medication PROCRIT (40,000 units/mL vial). The $14,839.22 firm fixed-price delivery order has an ultimate completion date of October 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10,000 units of the medication PROCRIT (10,000 units/mL vial). The $2,262.58 Firm Fixed Price contract is a Delivery Order that has a completion date of December 9, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This award is associated with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,488.38 firm fixed price delivery order is for the supply of 20,000 units of PROCRIT 20,000 units/mL vials. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 30, 2022. The $6,327.14 firm fixed-price delivery order is for the supply of 40,000 units/mL of the drug PROCRIT. The contract has a completion date of December 1, 2022 and is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,427.82 firm-fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT, with a completion date of September 13, 2024. This award is not set aside for a specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,026.26 firm fixed-price delivery order is for the supply of 40,000 units of PROCRIT 40,000 units/mL vials. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $2,617.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40,000 units/ml of the drug PROCRIT, a medication used to treat anemia. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 10,000 units of PROCRIT vials, a medication used to treat anemia. The contract has a firm fixed price of $6,263.07 and an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,670.15, is for the delivery of 10,000 units of PROCRIT 10,000 units/mL vials, with a completion date of February 14, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,029.56 firm fixed-price delivery order is for the supply of 10,000 units of PROCRIT (epoetin alfa) 10,000 units/mL vials. The award does not have a set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB23FT5BMDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,910.95 firm fixed-price delivery order is for the supply of 10,000 units of the medication PROCRIT 10,000 UNITS/ML VIAL. The award has an ultimate completion date of September 19, 2023 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veteran healthcare programs, and other federal medical institutions worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/18/23 |